ASSOCIATE GLOBAL PARTNERS LIMITED — Director's Dealing 2007

Aug 8, 2007

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity PROTEOME SYSTEMS LIMITED ABN 56 080 277 998

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	DR JENNY HARRY
Date of last notice	17 November 2006 – Appendix 3Y

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest	N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	8 August 2007
No. of securities held prior to change	Direct:
	2,228,415 Ordinary Shares
	4,906,781 Performance Rights
	Indirect:
	4,392 Ordinary Shares
Class	Ordinary Shares
Number acquired	596,781
Number disposed	N/A
Value/Consideration	Nil. Shares were issued pursuant to vesting
Note: If consideration is non-cash, provide details and estimatedvaluation	of performance rights issued under the
	Company’s Performance Rights Share Plan

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

Direct:2,825,196 Ordinary Shares4,310,000 Performance RightsIndirect:4,392 Ordinary Shares

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back

The shares were issued pursuant to thesatisfaction of the service vesting conditionsapplicable to performance rights granted toDr Harry under the Company’s PerformanceRights Share Plan. The issue of these sharesto Dr Harry was approved by shareholders atthe Company’s 2005AGM.Note that as a result of the share issue, therewas a commensurate reduction in the numberof performance rights held by Dr Harry.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002